Company Filing History:
Years Active: 2000-2004
Title: Innovations in Oncology: The Contributions of Biao Yang
Introduction: Biao Yang, a prominent inventor based in Winston-Salem, NC, has made significant contributions to the field of oncology through his innovative research and patents. With a total of two patents to his name, Yang's work focuses on the identification and application of specific biomarkers related to tumor cell proliferation.
Latest Patents: Yang's latest patents encompass the discovery of Sigma-2 receptors as biomarkers of tumor cell proliferation. His patent details detectably-labeled compounds of formula (I), wherein various components defined in the specification are utilized to facilitate competitive assays for the presence of Sigma-2 receptors. Additionally, the patents describe pharmaceutical compositions that contain these compounds and methods for their application, showcasing the potential impact of his research in clinical settings.
Career Highlights: Biao Yang is affiliated with Wake Forest University, where he actively engages in research aimed at improving cancer diagnostics and therapeutic strategies. His work has positioned him at the forefront of oncological innovation, contributing new insights that could potentially transform treatment paradigms for patients.
Collaborations: Throughout his career, Yang has collaborated closely with notable colleagues, including Robert H. Mach and Kenneth T. Wheeler. These partnerships have been instrumental in advancing his research endeavors and enhancing the overall impact of their findings within the scientific community.
Conclusion: Biao Yang represents a pivotal figure in the realm of medical innovation, particularly in oncology. His patents not only demonstrate his dedication to scientific excellence but also hold promise for the future of cancer diagnosis and treatment. As research continues to evolve, Yang's contributions will undoubtedly play a crucial role in shaping advancements in the fight against cancer.